HomeCSTL • NASDAQ
add
Castle Biosciences Inc
Previous close
$30.57
Day range
$30.76 - $31.19
Year range
$16.97 - $35.84
Market cap
850.74M USD
Avg Volume
420.64K
P/E ratio
153.96
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 85.78M | 39.50% |
Operating expense | 65.09M | 8.83% |
Net income | 2.27M | 132.86% |
Net profit margin | 2.65 | 123.60% |
Earnings per share | 0.08 | 130.77% |
EBITDA | 8.62M | 233.31% |
Effective tax rate | 72.60% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 279.78M | 21.78% |
Total assets | 514.56M | 18.01% |
Total liabilities | 73.51M | 46.33% |
Total equity | 441.06M | — |
Shares outstanding | 28.01M | — |
Price to book | 1.94 | — |
Return on assets | 2.53% | — |
Return on capital | 2.77% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 2.27M | 132.86% |
Cash from operations | 23.34M | 365.64% |
Cash from investing | -14.79M | -52.34% |
Cash from financing | 838.00K | 1,762.22% |
Net change in cash | 9.39M | 301.83% |
Free cash flow | 13.29M | 171.53% |
About
Founded
2007
Headquarters
Website
Employees
710
